FDA inspectors saw wrong Chinese plant (The Charlotte Observer)
U.S. health officials evaluated the wrong factory when assessing the safety of a Chinese-made drug ingredient that may be a source of problems with a blood thinner, the Food and Drug Administration said Monday. Baxter International's heparin has been linked to four deaths and hundreds of reports of allergic reactions. An investigation will take FDA inspectors to China this week. The Chinese ...

Mix-Up Behind FDA's Failure to Inspect China Blood-Thinner Plant (ABC 7 El Paso)
By Steven Reinberg , HealthDay Reporter MONDAY, Feb. 18 (HealthDay News) -- Due to a name mix-up, the U.S. Food and Drug Administration (FDA) failed to inspect a...